Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population
Autor: | Jose M. Reyes, Kerube Cerceño, Octavio Peralta, Patricio Gonzalez-Hormazabal, Carmen Romero, Teresa Bravo, Gabriella A. Di Capua, Gigia Roizen, Janara Pakomio, Sonia Margarit, Fernando Gomez, Gladys Ibañez, Enrique Waugh, Rafael Blanco, Lilian Jara |
---|---|
Rok vydání: | 2012 |
Předmět: |
Adult
Cancer Research Linkage disequilibrium MAP Kinase Kinase Kinase 1 Breast Neoplasms Single-nucleotide polymorphism Biology Polymorphism Single Nucleotide Linkage Disequilibrium Gene Frequency Genetic predisposition Humans Family Genetic Predisposition to Disease Age of Onset Chile Receptor Fibroblast Growth Factor Type 2 Allele Risk factor Allele frequency Genetics Haplotype Case-control study Haplotypes Oncology Case-Control Studies Female |
Zdroj: | Breast Cancer Research and Treatment. 137:559-569 |
ISSN: | 1573-7217 0167-6806 |
Popis: | Genome-Wide Association Studies have identified several loci associated with breast cancer (BC) in populations of different ethnic origins. One of the strongest associations was found in the FGFR2 gene, and MAP3K1 has been proposed as a low-penetrance BC risk factor. In this study, we evaluated the associations among FGFR2 SNPs rs2981582, rs2420946, and rs1219648; and MAP3K1 rs889312, with BC risk in 351 BRCA1/2-negative Chilean BC cases and 802 controls. All the SNPs studied were significantly associated with increased BC risk in familial BC and in non-familial early-onset BC, in a dose-dependent manner. Subjects with 3 risk alleles were at a significantly increased risk of BC compared with subjects with 0-2 risk alleles, in both familial BC and early-onset non-familial BC (OR = 1.47, 95 % CI 1.04-2.07, P = 0.026 and OR = 2.04 95 % CI 1.32-3.24, P < 0.001, respectively). In the haplotype analysis, the FGFR2 rs2981582 T / rs2420946 T / rs1219648 G haplotype (ht2) was associated with a significantly increased BC risk compared with the rs2981582 C / rs2420946 C / rs1219648 A haplotype in familial BC and in non-familial early-onset BC (OR = 1.32, 95 % CI 1.06-1.65, P = 0.012; OR = 1.46, 95 % CI 1.11-1.91, P = 0.004, respectively). When the FGFR2 ht2 and MAP3K1 rs889312 were evaluated as risk alleles, the risk of BC increased in a dose-dependent manner as the number of risk alleles increased (P trend |
Databáze: | OpenAIRE |
Externí odkaz: |